Strive Health Secures $550M to Revolutionize Kidney Care with AI and value-Based Models
Strive Health, a leading force in value-based kidney care, has announced a meaningful funding round totaling $550 million.This includes a $300 million Series D equity investment and $250 million in debt financing,positioning the company for substantial growth and impact. The investment underscores a growing recognition of the critical need to address kidney disease proactively and efficiently.
Key Highlights of the Funding:
Total funding: $550 million ($300M equity, $250M debt)
Led Equity Investor: New Enterprise Associates (NEA)
Additional Equity Investors: CVS Health Ventures, CapitalG, BlackRock, Inc. Debt Financing Lead: Hercules Capital
Strategic Impact: Expansion of partnerships, multi-specialty services, and AI-driven technology.
The Silent Epidemic: Addressing a critical Gap in Kidney Care
Kidney disease affects over 35 million Americans, yet a staggering 90% remain undiagnosed until the condition progresses to end-stage kidney disease (ESKD), frequently enough requiring dialysis or transplant. This late-stage diagnosis represents a critical gap in care, leading to higher costs and poorer patient outcomes. Strive Health is directly tackling this challenge.
The company’s innovative approach integrates artificial intelligence, proactive care interventions, and seamless collaboration with local healthcare providers. This creates a comprehensive, integrated care delivery system supporting patients throughout their entire kidney disease journey - from chronic kidney disease (CKD) to ESKD.
A Value-Based Model Delivering Proven Results
Strive Health partners with a diverse range of payors – including commercial and Medicare Advantage plans, as well as customary Medicare – and collaborates with health systems and physicians through flexible, value-based payment arrangements. This model prioritizes early intervention and preventative care, shifting the focus from reactive treatment to proactive health management.
The results speak for themselves:
20% Reduction: In total cost of kidney care. 41% Reduction: In hospitalizations.
94% Patient Satisfaction: Demonstrating a commitment to patient-centered care.
These outcomes are driven by a high-touch, preventative approach combined with cutting-edge AI solutions designed to lower the total cost of care and improve clinical results.
CareMultiplier™: The Technology Powering Change
At the heart of Strive Health’s success is CareMultiplier™, its proprietary technology platform. this platform is HITRUST certified, ensuring robust data security and compliance. furthermore, Strive’s case management and population health programs have earned accreditation from the National Committee for Quality Assurance (NCQA), validating their commitment to quality.
“When we founded Strive in 2018, the team set out to transform kidney care,” explains Chris riopelle, Co-Founder and CEO of Strive. “The continued investments…is a clear signal that the Strive team is delivering on that mission. By transforming kidney care, we will ultimately make the healthcare system work better for patients and providers.”
Expanding Reach and Impact
Currently, Strive Health collaborates with over 6,500 providers across all 50 states. The company manages nearly $5 billion in annual medical spending, impacting the lives of over 145,000 individuals. This substantial reach positions Strive health as a pivotal player in reshaping the future of kidney care, offering a model for improved outcomes and a more sustainable healthcare system.
This latest funding round will undoubtedly accelerate Strive Health’s mission, bringing its innovative solutions to even more patients and providers nationwide.